Mathematical Models of Cervical Cancer Prevention in the Asia Pacific Region

Vaccine

Volumn 26, Issue SUPPL. 12, 2008, Pages

  Goldie, Sue J ^a   Diaz, Mireia ^a,b   Kim, Sun Young ^a   Levin, Carol E ^c   Van Minh, Hoang ^d   Kim, Jane J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c PATH   (United States)

^d HANOI MEDICAL UNIVERSITY   (Viet Nam)

Author keywords

Asia Pacific; Cost effectiveness; HPV; Mathematical model

Indexed keywords

WART VIRUS VACCINE;

AGE DISTRIBUTION; ARTICLE; ASIA; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISABILITY; HEALTH CARE COST; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MATHEMATICAL MODEL; MORTALITY; PACIFIC ISLANDS; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIA; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; PACIFIC ISLANDS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 50849116079     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.018     Document Type: Article

References (50)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARC Press, 2004.
2. United Nations (UN), Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2004 Revision. CD-ROM Edition - Extended Dataset (United Nations publications, Sales No E 05 XIII 12), 2005.
3. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents. Vols. I-VIII. IARC CancerBase No. 7. Lyon: IARC Press, 2005.
4. de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 7 (2007) 453-459
5. Pham T.H., Nguyen T.H., Herrero R., Vaccarella S., Smith J.S., Nguyen Thuy T.T., et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 104 2 (2003) 213-220
6. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 1 (2003) 63-73
7. Denny L., Quinn M., and Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine 24 Suppl. 3 (2006) S71-S77
8. Suba E.J., Murphy S.K., Donnelly A.D., Furia L.M., Huynh M.L., and Raab S.S. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health 96 3 (2006) 480-487
9. Ramachandran S, Bhatla N, Virmani A, Bell L, Payne E, Dong L, et al., A fast affordable sensitive test for HPV in developing countries: performance trial results from India [Abstract PS6-59]. 24th International Papillomavirus Conference and Clinical Workshop, November 2007, Beijing, China; 2007. Abstracts book.
10. Sankaranarayanan R., Dinshaw K., Nene B.M., Ramadas K., Esmy P.O., Jayant K., et al. Cervical and oral cancer screening in India. J Med Screen 13 Suppl. 1 (2006) S35-S38
11. Sankaranarayanan R., Esmy P.O., Rajkumar R., Muwonge R., Swaminathan R., Shanthakumari S., et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu India: a cluster-randomised trial. Lancet 370 9585 (2007) 398-406
12. Sankaranarayanan R., Rajkumar R., Esmy P.O., Fayette J.M., Shanthakumary S., Frappart L., et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer 96 5 (2007) 738-743
13. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahé C., et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353 20 (2005) 2158-2168
14. World Health Organization (WHO). Statistical Information System: CHOICE (CHOosing Interventions that are Cost Effective). Available at: http://www.who.int/choice/en/.(last accessed: April 2008).
15. World Bank. World Development Indicators (WDI) Online. Available at: http://go.worldbank.org/6HAYAHG8H0.(last accessed: April 2008).
16. Garnett G.P., Kim J.J., French K., and Goldie S.J. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 24 Suppl. 3 (2006) S178-S186
17. Goldie S.J., Goldhaber-Fiebert J.D., and Garnett G.P. Chapter 18: Public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling. Vaccine 24 Suppl. 3 (2006) S155-S163
18. Goldie S.J., Kim J.J., and Myers E. Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine 24 Suppl. 3 (2006) S164-S170
19. Kim S.Y., and Goldie S.J. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics 26 3 (2008) 191-215
20. Newall A.T., Beutels P., Wood J.G., Edmunds W.J., and MacIntyre C.R. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis 7 4 (2007) 289-296
21. Goldie S.J., Kim J.J., Kobus K., Goldhaber-Fiebert J.D., Salomon J., O'Shea M.K., et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 25 33 (2007) 6257-6270
22. Goldhaber-Fiebert J.D., Stout N.K., Ortendahl J., Kuntz K.M., Goldie S.J., and Salomon J.A. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr 5 (2007) 11
23. Kim J.J., Kuntz K.M., Stout N.K., Mahmud S., Villa L.L., Franco E.L., et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol 166 2 (2007) 137-150
24. Kim J.J., Andres-Beck B., and Goldie S.J. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer 97 9 (2007) 1322-1328
25. Disease Control Priorities Project (DCPP). Available at: http://www.dcp2.org/main/Home.html.(last accessed: April 2008).
26. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., and Stoddart Ge. Methods for the economic evaluation of health care programs. 3rd edition (2005), Oxford University Press, New York, NY
27. In: Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, NewYork, NY
28. Franceschi S., Rajkumar T., Vaccarella S., Gajalakshmi V., Sharmila A., Snijders P.J., et al. Human papillomavirus and risk factors for cervical cancer in Chennai India: a case-control study. Int J Cancer 107 1 (2003) 127-133
29. Franceschi S., Rajkumar R., Snijders P.J., Arslan A., Mahe C., Plummer M., et al. Papillomavirus infection in rural women in southern India. Br J Cancer 92 3 (2005) 601-606
30. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 1 (2003) 101-105
31. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S26-S34
32. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
33. th International Papillomavirus Conference and Clinical Workshop. Beijing, China. November 2007. Abstracts book.
34. th International Papillomavirus Conference and Clinical Workshop. Beijing, China. November 2007. Abstracts book.
35. th International Papillomavirus Conference and Clinical Workshop. Beijing, China. November 2007. Abstracts book.
36. United Nations (UN), Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2006 Revision. CD-ROM Edition - Extended Dataset in Excel and ASCII formats (United Nations publication, Sales No E 07 XIII 7), 2007.
37. Murray C., and Lopez A.D. Estimating causes of death: new methods and global and regional applications for 1990. In: Murray C.J.L., and Lopez A.D. (Eds). The Global Burden of Disease and Injury Series (1996), Harvard University Press, Cambridge, MA 117-1120
38. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 2008, doi:10.1016/j.vaccine.2008.04.053, in press.
39. World Health Organization (WHO). Life tables for WHO member states: 2004. Available at: http://www.who.int/whosis/database/life_tables/life_tables.cfm.(last accessed: April 2008).
40. Acharya A., Diaz-Ortega J.L., Tambini G., de Quadros C., and Arita I. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine 20 27-28 (2002) 3332-3341
41. Kou U. Guidelines for estimating costs of introducing new vaccines into the national immunization system. Geneva: World Health Organization (2002), Department of Vaccines and Biologicals
42. Walker D., Mosqueira N.R., Penny M.E., Lanata C.F., Clark A.D., Sanderson C.F., et al. Variation in the costs of delivering routine immunization services in Peru. Bull World Health Organ 82 9 (2004) 676-682
43. Wolfson L.J., Gasse F., Lee-Martin S.P., Lydon P., Ahmed M., Tibouti A., et al. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Bull World Health Organ 86 1 (2008) 27-39
44. Goldhaber-Fiebert J.D., and Goldie S.J. Estimating the cost of cervical cancer screening in five developing countries. Cost Eff Resour Alloc 4 (2006) 13
45. Kim JJ, Kobus KE, Diaz M, O'Shea M, Goldie SJ. Cost-effectiveness of cervical cancer prevention in Vietnam. Vaccine 2008, doi:10.1016/j.vaccine.2008.05.038, in press.
46. Diaz M., Kim J., Albero G., et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. BJC 99 2 (2008) 230-238
47. World Health Organization (WHO). Macroeconomics and health: investing in health for economic development: report of the commission on macroeconomics and health. Geneva: World Health Organization, 2001.
48. Kim J., Brisson M., Edmunds W.J., and Goldie S.J. Modeling Cervical Cancer Prevention in Developed Countries. Vaccine 26 Suppl 11 (2008)
49. IAVI/PATH. HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues. 2007 International AIDS Vaccine Initiative/Program for Appropriate Technology in Health (PATH). Available at: http://www.iavi.org/file.cfm?fid=47496. (last accessed: June 2008).
50. Kim S.Y., Salomon J.A., and Goldie S.J. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bull World Health Organ 85 11 (2007) 833-842